Study examined NOTCH1 mutations as a predictor of response to BTK inhibitors in patients with CLL.
Home / Resource Library / NOTCH1 Mutation Is Associated With Response to Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: A Retrospective Study